| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3086156 | Pediatric Neurology | 2008 | 8 Pages |
Abstract
More accurate documentation of a neonate's specific hypertonic state could be helpful as part of serial neurologic examinations. The clinician would then be in a more advantageous position to choose the appropriate neuroprotective drug or the procedure that best fits with the etiology, localization, and timing of injury. Ideally, choices for neuroprotection will integrate history, examination, and diagnostic findings before considering options for prophylaxis, neurorescue, or neurorepair. Measuring the efficacy of a neuroprotection protocol should include a complete list of life-course challenges, including motor, epileptic, cognitive, and behavioral outcomes as expressed at successively older ages.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Mark S. Scher,